Are the new selective alpha-blockers better than non-selective alpha-blockers for benign prostatic hyperplasia?

. 1998 Dec;44:2659–2662.

PMCID: PMC2277790 PMID: 9870119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Buzelin J. M., Fonteyne E., Kontturi M., Witjes W. P., Khan A. Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group. Br J Urol. 1997 Oct;80(4):597–605. doi: 10.1046/j.1464-410x.1997.00205.x. [DOI] [PubMed] [Google Scholar]
Lee E., Lee C. Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses. Br J Urol. 1997 Oct;80(4):606–611. doi: 10.1046/j.1464-410x.1997.00411.x. [DOI] [PubMed] [Google Scholar]
de Mey C., Michel M. C., McEwen J., Moreland T. A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing. Eur Urol. 1998;33(5):481–488. doi: 10.1159/000019639. [DOI] [PubMed] [Google Scholar]